Cargando…
N(6)-methyladenosine reader IGF2BP3 as a prognostic Biomarker contribute to malignant progression of glioma
BACKGROUND: Glioblastoma (GBM) is a highly aggressive cancer having a dismal prognosis. N(6)-methyladenosine (m(6)A) is closely related to GBM progression. The significance of m(6)A modifications depends on the m(6)A readers, whose functions in glioma progression are largely unknown. This study soug...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174994/ https://www.ncbi.nlm.nih.gov/pubmed/37180667 http://dx.doi.org/10.21037/tcr-23-449 |